We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,640.50
Bid: 1,640.00
Ask: 1,640.50
Change: 4.50 (0.28%)
Spread: 0.50 (0.03%)
Open: 1,642.00
High: 1,656.00
Low: 1,635.00
Prev. Close: 1,636.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3 Feb 2022 13:00

Price of COVID treatments from Pfizer, Merck, GSK align with patient benefits -report

By Deena BeasleyFeb 3 (Reuters) - The prices of drugs used to treat COVID-19 for those at risk of serious illness are "reasonably aligned" with how much they help patients, according to a draft report from drug-pricing research organization the In...

Read more
2 Feb 2022 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
2 Feb 2022 09:09

TOP NEWS: GSK's ViiV gets USD1.25 billion from Gilead patent pact

TOP NEWS: GSK's ViiV gets USD1.25 billion from Gilead patent pact

Read more
2 Feb 2022 07:54

Glaxo's ViiV Healthcare settles patent row with Gilead

(Sharecast News) - Specialist HIV company Viiv Healthcare - which is majority-owned by GlaxoSmithKline with Pfizer and Japan's Shionogi as shareholders - has settled a global patent infringement litigation with Gilead Sciences.

Read more
1 Feb 2022 15:05

Glaxo's ViiV Healthcare gets FDA approval for HIV treatment

(Sharecast News) - The US Food and Drug Administration has approved ViiV Healthcare's Cabenuva (cabotegravir, rilpivirine) for the treatment of HIV-1 in virologically-suppressed adults.

Read more
1 Feb 2022 14:51

GSK's Viiv Healthcare gets FDA approval for new dose of HIV treatment

GSK's Viiv Healthcare gets FDA approval for new dose of HIV treatment

Read more
31 Jan 2022 12:34

INSIGHT-Merck's COVID pill is last choice for U.S. patients, global use varies

By Deena BeasleyJan 31 (Reuters) - Merck & Co's new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four available options for at-risk patients given its relatively low efficacy and potential...

Read more
31 Jan 2022 11:00

EXPLAINER-How does Merck's COVID-19 pill compare to Pfizer's?

By Deena BeasleyJan 31 (Reuters) - Rival antiviral pills from Pfizer Inc and Merck & Co that demonstrated efficacy in trials of adults with COVID-19 who are at high risk of serious illness are now both in use. The drugs are being studied to see ...

Read more
31 Jan 2022 09:22

PRESS: Activist investor Cevian builds stake in Vodafone - Bloomberg

PRESS: Activist investor Cevian builds stake in Vodafone - Bloomberg

Read more
28 Jan 2022 09:59

LONDON BROKER RATINGS: Barclays lifts ITV and S4 Capital to Overweight

LONDON BROKER RATINGS: Barclays lifts ITV and S4 Capital to Overweight

Read more
27 Jan 2022 10:09

LONDON BROKER RATINGS: Fresnillo and Polymetal hit by downgrades

LONDON BROKER RATINGS: Fresnillo and Polymetal hit by downgrades

Read more
25 Jan 2022 17:33

Unilever undergoes "spring clean" amid investor pressure

Unilever undergoes "spring clean" amid investor pressure

Read more
25 Jan 2022 14:30

FOCUS-Trian expected to revive its P&G playbook with Unilever

By Svea Herbst-BaylissBOSTON, Jan 25 (Reuters) - Two and a half years ago Nelson Peltz, the billionaire activist investor who often presents himself as a partner with constructive advice for companies, told an audience of pension and hedge funds t...

Read more
25 Jan 2022 10:53

TIMELINE-Unilever's soap opera: M&A, job cuts and grumpy investors

Jan 25 (Reuters) - Unilever unveiled plans on Tuesday to cut about 1,500 management jobs in an overhaul aimed at easing shareholders' concerns after a failed acquisition and news an activist investor had built a stake in the consumer goods giant....

Read more
25 Jan 2022 09:56

TOP NEWS: Under pressure Unilever to cut 1,500 jobs amid restructure

TOP NEWS: Under pressure Unilever to cut 1,500 jobs amid restructure

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.